Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Life phases
- Important concepts of senescent phenotypes
- 77 human senescent phenotypes
- Hypertension
- The kidney
- The structure of the circulatory system
- The aging kidney
- Incidence of kidney failure
- Gene interaction network salt-Induced changes
- Etiology of hypertension
- Atherosclerosis
- Leukocyte extravasation
- Stages of artherosclerosis
- NFκβ - Inflammatory pathways and receptors
- Alzheimer’s disease
- Different parts of the brain
- Loss of neurons and of synaptic density with age
- Age course of genes altered with brain aging
- Loss of neural activity and decreased input signals
- Aβ oligomers & acute inflammatory response
- Conserved epigenomic signals, AD immune basis
- High idea density and longevity
- Genetic factors predisposing to AD
- Diabetes, type 2
- Adipose tissue cells
- Upstream inducers of cellular stress
- Effect of glycation endproducts/ROS on diabetes
- Gastro-intestinal cancers
- Alteration of intestinal microbiota and longevity
- Intestine is directly involved in longevity signaling
- Intestinal inflammation and cancer
- Sporadic vs. colitis associated colon cancer
- Muscle aging
- Joint effects of 8 different complex processes
- Lack of growth factors
- Circulating growth factors and heterochronic effect
- ROS & loss of mitochondria
- Events result in the death of muscle cells
- Skin aging
- The skin structure
- Age-related thinning & loss of complex structure
- Genesis of our wrinkles
- Resistance to mechanical blistering of skin
- Senescent cells have a destructive phenotype
- Senescence via several converging pathways
- Metabolic syndrome
- Metabolic syndrome in rats
- Inflammosomes and aging
- PAMPs and DAMPs
- Inflammasomes and their activators
- The seven human senescent phenotypes
- Genes, traits, tissues & disease relationship
- The senescent stage may be reversible
- Overview of antiaging interventions
- Pros & cons of pro-longevity interventions
- Thank you
Topics Covered
- Life phases and human senescent phenotypes
- Seven major human senescence phenotypes
- Hypertension
- Atherosclerosis
- Alzheimer’s disease
- Diabetes type 2
- Muscle aging
- Gastrointestinal cancers
- Skin aging
- Inflammasomes and aging
Talk Citation
Arking, R. (2016, June 30). Human senescent phenotypes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 4, 2024, from https://doi.org/10.69645/TZQR6227.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert Arking has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Aging
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Robert Arking,
I'm a professor
of Biological Sciences
at Wayne State University.
I've long been interested
in understanding
the genetic aspects
of the biology
of longevity and aging.
I've been asked to discuss
with you today
the topic of human
senescent phenotypes,
what are they,
how do they begin,
do they use the same
or different mechanisms,
can they be averted,
and most interestingly,
can they be reversed.
Let us begin.
0:26
We experience our life
as being a long
and continuous
sequence of events.
Our conscious experience is not,
however, a reliable guide,
for the lifespan
is actually composed
of several different phases.
Each distinguished by different
patterns of gene expression,
functional levels,
and mortality rates.
These phases
are the developmental span,
the health span,
the transition phase,
and then the senescent span.
The developmental span
begins at our conception,
or for certain epigenetic
based events,
it might well begin
when your mother was a fetus
in your grandmother's womb.
Much of this phase is concerned
with proper physical
and mental development
and ends by about
20 years of age
when we reach
our maximum physical fitness.
The minimum human age specific
mortality rate has reached
just prior to sexual maturation.
Humans differ from most
other mammals in the fact
that we are sexually mature
long before
we are developmentally mature.
The health span occurs roughly
from ages 20 to 55 or 60 or so.
Gene-dependent longevity
assurance mechanisms
are operative.
There are high levels of repair
and maintenance,
high levels of homeostasis,
and sufficient reserve capacity
to deal with various stressors.
If you are healthy,
the age specific mortality rate
usually increases
at a very slow rate
and is at a low level
to begin with.
The transition phase
is when the age
specific mortality
begins
to significantly increase,
beginning
at about 55 to 60 years.
When the age related
senescent human phenotypes
begin to make themselves felt
and experienced.
The senescent phase extends
form age 55
until the end of life.
And many senescent phenotypes
that steal away
our functional ability
are highly individualized.
In all cases, what occurs
is that the cells burden
of damage increases
and we undergo
a loss of homeostasis.
Eventually,
a critical threshold is passed
and cell function ceases.
Note that aging can be reversed
in certain highly controlled,
entirely different situations
in laboratory animals.
Thus, the idea that aging
is non-reversible
is not strictly true.
But there are for now
no obvious ways
of translating
these exceptional reversals
into a more ordinary event.
Although the research
is very encouraging, I must say.
Perhaps, one of you might be
involved in that work some day.
Thus the senescent human
phenotypes occur mostly
during the last 20 years
of the ordinary human life
but as you will see,
they mostly have
their beginnings
much earlier
in the health span.